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Abstract Rationale: There is disagreement in the
literature with respect to how drugs of abuse affect the
functioning of the hypothalamic–pituitary–adrenal (HPA)
axis, and whether these changes in endocrine function may
be related to the rewarding effects of these drugs.
Objectives: To determine whether reinforcing drugs with
different mechanisms of action affect HPA axis function at
doses at which they serve as reinforcers. Methods: Seven
monkeys (6 male) were randomly assigned to self-
administer methohexital—a barbiturate (n=4), midazolam
—a benzodiazepine (n=3), or ethanol (n=5). Each monkey
had a surgically implanted indwelling venous catheter, and
was trained to respond on a fixed ratio of 30 lever presses
to receive an injection of drug or saline. Blood samples
were obtained before, during, and after the self-adminis-
tration sessions for the measurement of ACTH and cortisol
by radioimmunoassay. Results: Although methohexital,
midazolam, and ethanol all maintained self-administration
behavior across a range of doses, they differed in their
effects on ACTH and cortisol. Ethanol inhibited ACTH
and cortisol secretion. Methohexital and midazolam both
tended to decrease ACTH and cortisol at large doses, and
increase these hormones at small doses, but the HPA
effects of neither drug differed significantly from when
saline was available. Conclusions: The neutral overall
effect of methohexital and midazolam on HPA activity is
consistent with other monkey and human studies, whereas
the inhibitory effect of self-administered ethanol in the
monkey contrasts with both the rat and human literature.
The data in this study suggest that a change in HPA axis
activity is not a requirement for drug-reinforced behavior
in monkeys.
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Introduction
Some drugs of abuse have a propensity for stimulating the
hypothalamic–pituitary–adrenal (HPA) axis, increasing the
secretion of the “stress hormones”, adrenocorticotropin
(ACTH) and cortisol, into the circulation. This stimulatory
effect has been consistently measured following the
administration of psychomotor stimulants such as cocaine
in rat (Galici et al. 2000), rhesus monkey (Broadbear et al.
1999) and human studies (Mendelson et al. 2002).
Although the effects of other classes of abused drugs on
endocrine endpoints have also been studied, the literature
contains fundamental points of disagreement. These
differences may have their origin in species differences,
or may have more to do with the experimental procedures
that were employed. More research is needed to address
these issues and enable meaningful comparisons of the
HPA effects of a wider range of drugs of abuse to be made.
Barbiturates are readily self-administered by mice
(Carney et al. 1991), rats (Ator and Griffiths 1987), rhesus
monkeys (Winger et al. 1975; Vanover et al. 1989),
baboons (Griffiths et al. 1991) and humans (Griffiths et al.
1979). A number of studies have demonstrated the
reinforcing effectiveness of a wide range of barbiturates,
but none have characterized the effects of self-adminis-
tered barbiturates on pituitary–adrenal function. Barbitu-
rates are thought to exert their effects by binding at a site
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on the γ-amino-butyric acid (GABAA) receptor complex
and enhancing the inhibitory actions of GABA (Mehta and
Ticku 1999). There is evidence that GABA is a potent
inhibitor of CRH secretion in vivo as measured by its
inhibition of ACTH release (Makara and Stark 1974).
Intracerebroventricular administration of GABA to rats
inhibits the release of CRH from the hypothalamus into
portal blood (Plotsky et al. 1987). There is evidence that
treatment with an anesthetizing dose of a barbiturate does
not affect basal HPA axis activity (Buckingham 1984;
D’Haese and Camu 1993) or interfere with subsequent
stimulation of the HPA axis by exogenous administration
of either corticotropin (ACTH; Barrett and Stockham
1965; Borner et al. 1985) or CRH (Broadbear et al.
2004a). However, other studies report that although
barbiturates themselves may not affect HPA axis activity,
they can attenuate the stimulatory effect of other
treatments such as ether (Greer and Rockie 1968) or
morphine injection (Buckingham 1984) on HPA measures.
Although benzodiazepines serve as reinforcers in rats,
monkeys and humans (see review by Ator and Griffiths
1987), they maintain lower rates of responding than do
barbiturates (Yanagita and Takahashi 1973); short-acting
benzodiazepines maintain the highest rates of responding
among the benzodiazepines (Griffiths et al. 1981). Like
barbiturates, benzodiazepines produce their effects at the
GABAA receptor complex, although at a distinct benzo-
diazepine-binding site (Mehta and Ticku 1999). Although
the effect of benzodiazepines on the HPA axis in rats
appears to be dependent on the dose that is used (Pericic et
al. 1984; Kalman et al. 1997), their effects on both
monkey (Kalogeras et al. 1990) and human ACTH and
cortisol secretion appear to be inhibitory (Charney et al.
1986). For example, prior treatment with temazepam
significantly attenuates the stimulatory effects of exoge-
nous CRH on ACTH and cortisol secretion in humans
(Korbonits et al. 1995).
Ethanol also serves as a reinforcer in rhesus monkeys by
both the intravenous (IV; Williams et al. 2004) and oral
routes (Williams et al. 1998). Although ethanol’s mech-
anism of action continues to be debated, the similarity of
its effects to those of the barbiturates and benzodiazepines
suggest that the GABAA receptor may also be sensitive to
the actions of ethanol (Davies 2003). When ethanol is
administered intraperitoneally to unanesthetized, freely
moving rats, it produces an increase in plasma ACTH and
corticosterone that is blocked by pretreatment with CRH-
antiserum (Rivier et al. 1984). In ewes also, intravenous
infusion of different doses of ethanol results in a somewhat
dose-dependent stimulation of ACTH and cortisol (Cudd
et al. 1996). Studies in humans variously report that
ingestion of ethanol results in no effect (Stott et al. 1987;
Ida et al. 1992) or in stimulation of the HPA axis (Schuckit
et al. 1987; Lukas and Mendelson 1988; Schuckit et al.
1988; McCaul et al. 2001).
This study was designed to investigate whether sedative
drugs, at doses that are self-administered, affect HPA axis
activity in rhesus monkeys. Specifically, we have
attempted to characterize the relationship between drug
(methohexital, midazolam, or ethanol) intake and changes
in basal ACTH and cortisol secretion. On the basis of
evidence already published, it was predicted that metho-
hexital and ethanol would fail to alter HPA axis activity,
and that midazolam would dose-dependently decrease
ACTH and cortisol levels.
Materials and methods
Subjects
Six adult male rhesus monkeys (Macaca mulatta),
weighing between 9.8 kg and 15.4 kg, and one female
monkey, weighing 8.2 kg, were the subjects for this study.
All subjects had an extensive self-administration history
with two or more classes of drug, including cocaine and
methohexital. The monkeys were randomly assigned to the
three drug groups; methohexital (n=4), midazolam (n=3)
and ethanol (n=5). One monkey (3030) was tested with all
three drugs, one monkey (3147) was tested with both
methohexital and ethanol, one monkey (3596) was tested
with both midazolam and methohexital, and one monkey
(3151) was tested with both midazolam and ethanol. The
remaining monkeys were tested with either ethanol (2489,
2487 female) or methohexital (monkey 2595).
Apparatus
Each individually housed monkey had a surgically placed
indwelling venous catheter in a femoral, internal, or
external jugular vein. Housing and surgical details can be
found in Broadbear et al. (2004b). The outer portion of the
catheter was protected inside the cage by a flexible
stainless steel tether, with one end attached to a double
layer polyester jacket (Lomir, New York, N.Y., USA)
worn by the monkey and the other bolted to the rear of the
cage. Each cage had a 15×20 cm panel fixed to its right
wall. Each panel had three stimulus lights, two red and one
central green light, placed above two response levers. The
red stimulus light over the right lever signaled drug
availability. The green center light was illuminated for the
duration of the drug or saline injection, 1 ml per 5 s.
During a time-out, all stimulus lights were extinguished
and responding had no programmed consequences. The
experiment was controlled using IBM/PS2 computers
located in an adjacent room. The computers were
programmed using Med Associates software (Georgia,
Vt., USA).
Procedure
The procedure used in this study has been described
previously (Broadbear et al. 2004b). Drug self-adminis-
tration sessions were scheduled twice daily for 130 min
starting at approximately 10 a.m. and 4 p.m. Saline was
substituted on a frequent basis (25–50% of sessions), with
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saline sessions randomly interspersed between drug
sessions. The reinforcing effectiveness of and stress
hormone response to methohexital (0.01, 0.03, 0.1, 0.3
and 1.0 mg/kg/inj), midazolam (0.001, 0.003, 0.01, and
0.03 mg/kg/inj), and ethanol (0.003, 0.01, 0.03, and 0.1 g/
kg/inj) were evaluated. Drug or saline delivery was
contingent on each monkey emitting a fixed ratio of 30
lever presses (FR=30). A 1-ml aliquot of each drug
concentration or saline was injected every 5 s. With the
exception of ethanol, the duration of each drug injection
was 5 s. Dose of ethanol (30%, w/v concentration) was
regulated by varying the injection duration, which ranged
from 2 s to 35 s depending on the required dose and the
weight of the subject. There was a 10-s time out (TO)
between the end of an injection and the next response
opportunity. The 2 h 10 min session was divided into four
25 min components, each separated by a 10-min time out
during which venous blood was drawn during test
sessions. A single dose of drug or saline was available
each session (two sessions per day). During test sessions,
blood was sampled before, during and after the session on
at least two occasions for each drug dose as well as for
saline. When changing to a different dose of the same
drug, the new dose was made available during self-
administration sessions, with blood sampling only resum-
ing once the response stability criterion was reached (see
below). The self-administration behavior of the four
monkeys that were tested with more than one drug was
evaluated for at least a week after switching from one drug
to another, and testing did not commence until responding
for the new drug had stabilized. A stable baseline of self-
administration behavior was defined as consistency (<15%
variability in the number of injection earned) across three
sessions in responding for the drug dose of interest. The
order of presentation of the drug doses was varied
randomly. Blood was sampled for the measurement of
ACTH and cortisol at 15 min and 5 min prior to the self-
administration session, as well as during (25, 60, 95, and
130 min) and after the session (2 h 45 min, 3 h 20 min, 4 h
20 min, and 5 h 20 min). All experiments reported in this
study were conducted during the morning self-adminis-
tration session.
Blood collection and handling
Blood samples were collected from the monkeys in the
self-administration study via their indwelling venous
catheters. The collection, handling and storage procedures
that were used have been described previously (Broadbear
et al. 2004b). ACTH and cortisol levels were determined
using commercially available radioimmunoassay kits
(ACTH: Nichols Institute Diagnostics, San Juan Capis-
trano, Calif., USA; Cortisol: Diagnostic Products Corpora-
tion, Los Angeles, Calif., USA). The limit of detection of
the cortisol assay was 0.2 μg/dl, while the intra-assay and
inter-assay coefficients of variation were 5% and 6.5%,
respectively. The limit of detection for the ACTH assay
was 0.5 pg/ml, with intra-assay and inter-assay coefficients
of variation of 3% and 7%, respectively.
Data analysis
Self-administration data (responses per second, mean
number of injections and drug intake) were obtained
from morning sessions during which blood samples were
collected. Response rate was calculated by dividing the
total number of lever presses executed during the session
by the cumulative time that the red light was illuminated.
Data were averaged across subjects and plotted against
each dose of each drug along with the standard error of the
mean (SEM). The data were analyzed for dose dependency
and differences across the sampling time.
ACTH and cortisol levels that were measured in plasma
during saline, methohexital, midazolam, and ethanol self-
administration are presented as mean±SEM. The effects of
saline self-administration on ACTH and cortisol secretion
among the drug-taking groups were compared, prior to
comparisons of the HPA effects of saline and each drug
dose within each of the drug-taking groups. There was
some individual variation in the pre-session ACTH and
cortisol measurements. Therefore, the raw ACTH and
cortisol data for each drug dose were standardized by
subtraction of the averaged pre-session ACTH or cortisol
value from the subsequent samples prior to graphing and
statistical analysis. Except in the case of the saline
comparison, within-drug (but not between drug) data
analysis was carried out.
Summary data are shown prior to and subsequent to
transformation to area under curve (AUC) calculation.
AUC values are an estimate of the total ACTH (pg min/
ml) and cortisol (μg min/dl) released during the session
relative to pre-session levels. AUC values were calculated
according to the trapezoidal rule (e.g. Tallarida and
Murray 1987). Plasma ACTH and cortisol AUCs were
analyzed for dose-related drug effects on HPA axis
hormones.
Analysis of variance (ANOVA) was conducted for all of
the comparisons described above, using one or two within-
subject variables (dose and sampling time) and one
between-subject variable (in the case of the saline
comparison across the different drugs). Where appropriate,
post hoc pairwise comparisons using the Tukey Honest
Significant Difference test of significance (P<0.05) were
carried out (Statistica v.5.0; Statsoft, Tulsa, Okla., USA).
Drugs
Methohexital was purchased from Ace Surgical Supplies
(Brockton, Mass., USA) and diluted with sterile water.
Midazolam (50 mg/10 ml) was purchased from Abbott
Laboratories (N. Chicago, Ill., USA). Ethanol (95%, 190%
proof) was purchased from Pharmco (Brookfield, Conn.,
USA). Methohexital and midazolam dilutions were made
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using sterile saline. Ethanol (95%) was diluted in saline to
make a 30% (w/v) solution.
Results
Saline ACTH and cortisol secretion was compared during
the sessions in which saline was available for self-
administration by three groups of monkeys that alterna-
tively had access to one of methohexital, midazolam or
ethanol, with “group” as the between-subjects factor. The
secretory patterns of ACTH and cortisol when saline was
available did not differ among the three groups, although
there was an effect of sampling time [ACTH: F(7,63)
=6.72, P<0.05; cortisol: F(7,63)=5.83, P<0.05] which
indicated that ACTH and cortisol levels for all three
groups were elevated at the 130, 165, 200 and 260 min
time points relative to the 25, 60, and 320 min sampling
times. In addition, the secretory pattern of cortisol for the
three drug groups differed as indicated by a group–
sampling time interaction [F(14,63)=2.13, P<0.05]. Dur-
ing saline availability, the rise in cortisol levels in
monkeys in the midazolam group was smaller than those
measured in the methohexital and ethanol groups during
saline availability.
Methohexital Responding for methohexital generated a
bell-shaped function, with a significant effect of dose [F
(5,10)=58.02, P<0.05]. A maximum response rate of 0.46
±0.03 responses/s was maintained by injections of 0.1 mg/
kg/inj methohexital. Total intake of methohexital increased
as a function of the available dose, with peak intake
ranging from 17.0 mg/kg to 25.3 mg/kg when the largest
dose (1.0 mg/kg/inj) of methohexital was available
(Fig. 1A).
Baseline ACTH and cortisol levels prior to sessions
during which methohexital was tested were 6.6±0.60 pg/
ml and 13.7±0.74 μg/dl, respectively. Self-administration
of methohexital did not significantly affect the secretion of
ACTH or cortisol relative to saline during the session.
However, there was a tendency for the smaller methohex-
ital doses to increase and for the larger doses to suppress
ACTH secretion [F(35,105)=2.24, P<0.05; Fig. 1B,C].
There was some evidence for a rebound effect, as there
was a trend towards an increase in ACTH and cortisol
levels, relative to saline and the smaller doses, following
sessions in which 0.3 mg/kg/inj and 1.0 mg/kg/inj
methohexital were available (Fig. 1B,C). When the
cumulative release of both cortisol and ACTH during the
self-administration session was examined, the larger doses
appeared to suppress hormone secretion relative to the
smaller doses [ACTH: F(5,15)=9.40, P<0.05; cortisol: F
(5,15)=4.15, P<0.05; Fig. 1D]. In the case of ACTH,
1.0 mg/kg/inj methohexital resulted in reduced ACTH
levels relative to when 0.01 mg/kg/inj methohexital was
available (P<0.05). Similarly for cortisol, self-administra-
Fig. 1 A Response rate (responses/s) and drug intake (mg/kg) for
monkeys trained to lever press on a fixed ratio of 30 responses for
each injection of the barbiturate, methohexital (mg/kg/inj) or saline
(n=4). B, C Change in plasma concentrations of ACTH (B; baseline
= 6.6±0.60 pg/ml) and cortisol (D; baseline = 13.7±0.74 μg/dl)
measured in venous blood samples obtained before, during (in box)
and after sessions during which saline or methohexital was available
for self-administration. D Cumulative release of ACTH (pg min/ml)
and cortisol (μg min/dl) during self-administration of methohexital
or saline. The zero line on the Y axis indicates the average pre-
session hormone levels. Key to symbols: a Self-administration rates
significantly different from 0 (saline), 0.01, 0.03 and 1.0 mg/kg/inj
methohexital, b ACTH levels significantly different from 0.01 mg/
kg/inj and 0.03 mg/kg/inj methohexital (not shown), c ACTH levels
significantly different from 0.01 mg/kg/inj methohexital, d cortisol
levels significantly different from 0.01 mg/kg/inj methohexital
86
tion of 0.01 mg/kg/inj and 0.03 mg/kg/inj methohexital
resulted in an increase in cortisol secretion relative to
when 0.1, 0.3 and 1.0 mg/kg/inj methohexital were
available (P<0.05).
Midazolam Responding for midazolam also generated a
bell-shaped function, with a significant effect of dose [F
(4,8)=13.05, P<0.05]. A maximum response rate of 0.15
±0.02 responses/s was maintained by injections of
0.01 mg/kg/inj midazolam. Total intake of midazolam
increased as a function of the available dose, with peak
intake ranging from 0.62 mg/kg to 0.87 mg/kg when the
largest dose (0.03 mg/kg/inj) of midazolam was available
(Fig. 2A).
Baseline ACTH and cortisol levels prior to sessions
during which midazolam was tested were 5.9±0.87 pg/ml
and 11.0±0.57 μg/dl, respectively. There was a significant
effect of midazolam dose across sampling times; smaller
doses increased, and larger doses decreased ACTH
concentrations during the session [F(4,8)=5.16, P<0.05].
The smallest dose of midazolam (0.001 mg/kg/inj)
increased ACTH secretion relative to when the largest
dose (0.03 mg/kg/inj) of midazolam was available
(P<0.05; Fig. 2B). There was a similar trend for the effect
of midazolam on cortisol, with the smallest dose
producing a higher concentration of cortisol than did the
largest dose (P<0.05), but neither dose differed signifi-
cantly from saline in its effect on cortisol (Fig. 2C). When
the cumulative release of both ACTH and cortisol during
the self-administration session were examined, the AUC
for both hormones decreased as the dose of midazolam
increased [ACTH: F(4,8)=10.97, P<0.05; cortisol: F(4,8)
=3.53, P<0.05; Fig. 2D]. This decrease in cumulative
cortisol and ACTH secretion was significant relative to the
stimulatory effect of the smaller doses of midazolam but
not to the ACTH and cortisol responses when saline was
available.
Ethanol Responding for ethanol generated a bell-shaped
function, with a significant effect of dose [F(4,12)=5.72,
P<0.05]. A maximum response rate of 0.45
±0.08 responses/s was maintained by injections of
0.03 g/kg/inj ethanol. Total intake of ethanol increased
as a function of the available dose, with peak intake
ranging from 1.2 g/kg to 3.0 g/kg when the largest dose
(0.1 g/kg/inj) of ethanol was available (Fig. 3A).
Baseline ACTH and cortisol levels prior to sessions
during which ethanol was tested were 6.0±0.41 pg/ml and
12.1±0.58 μg/dl, respectively. ACTH and cortisol secre-
tion decreased during self-administration of 0.01 (cortisol
only), 0.03 g/kg/inj and 0.1 g/kg/inj ethanol [ACTH: F
(4,12)=4.16, P<0.05; Fig. 3B, and cortisol: F(4,12)=13.91,
P<0.05; Fig. 3C] relative to when saline, or 0.003 g/kg/inj
ethanol (in the case of cortisol) were available for
Fig. 2 A Response rate (responses/s) and drug intake (mg/kg) for
monkeys trained to lever press on a fixed ratio of 30 responses for
each injection of the benzodiazepine, midazolam (mg/kg/inj) or
saline (n=3). B, C Change in plasma concentrations of ACTH (B;
baseline = 5.9±0.87 pg/ml) and cortisol (C; baseline=11.0±0.57 μg/
dl) measured in venous blood samples obtained before, during (in
box) and after sessions during which saline or midazolam was
available for self-administration. D Cumulative release of ACTH
(pg min/ml) and cortisol (μg min/dl) during self-administration of
midazolam or saline. Key to symbols: a Rates of responding
significantly different from 0 (saline) and 0.001 mg/kg/inj
midazolam, b ACTH response significantly different from
0.001 mg/kg/inj midazolam, c ACTH and cortisol levels signifi-
cantly different from 0.003 mg/kg/inj midazolam, d Cortisol
response significantly different from 0.001 mg/kg/inj midazolam
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injection. This ethanol-related inhibition of ACTH and
cortisol secretion continued for several hours following the
end of the session (P<0.05). When the cumulative release
of both cortisol and ACTH during the self-administration
session was examined, the AUC for both hormones
diminished during self-administration of larger doses of
ethanol [ACTH: F(4,12)=20.33, P<0.05; cortisol: F(4,12)
=5.15, P<0.05; Fig. 3D]. Both 0.03 g/kg/inj and 0.1 g/kg/
inj ethanol attenuated ACTH release relative to when
saline, 0.003 g/kg/inj or 0.01 g/kg/inj ethanol were
available (P<0.05). Self-administration of 0.03 g/kg/inj
and 0.1 g/kg/inj ethanol resulted in decreases in cortisol
release relative to when saline was available (P<0.05).
Discussion
In this study, we measured the effects of self-administered
methohexital, midazolam or ethanol on the secretion of
ACTH and cortisol in rhesus monkeys. The pre-session
(basal) ACTH and cortisol levels were low as previously
reported (Broadbear et al. 1999), indicating that the
monkeys were habituated to their surroundings and to
the experimental procedure. Each of these drugs main-
tained behavior across a range of doses, as evident from
the bell-shaped curves generated in response to drug
availability. The predictions regarding the effects of drug
intake on HPA axis activity were not supported by the
results of this study. Originally it was postulated that
midazolam would attenuate HPA axis activity, and that
neither methohexital nor ethanol would change ACTH and
cortisol secretion relative to when saline was available.
Instead, for both methohexital and midazolam, self-
administration of small doses stimulated ACTH and
cortisol relative to the apparent attenuation of secretion
that was observed with self-administration of the larger
doses. Neither the small nor the large doses differed
significantly from saline in their effects on ACTH and
cortisol. Conversely, at the doses self-administered in this
study, ethanol dose-dependently inhibited the secretion of
ACTH and cortisol. The biphasic changes in hormone
secretion measured during saline self-administration are
likely to be a consequence of diurnal variation as they also
occur in the absence of the self-administration session
(Broadbear et al. 1999).
Our finding that self-administration of methohexital had
no effect on HPA axis activity relative to when saline was
available is consistent with other reports of a neutral effect
of larger, anesthetizing doses of barbiturates on stress axis
hormones (Buckingham 1984; D’Haese and Camu 1993).
During the course of other studies in this laboratory, we
examined the effect of brief anesthetization with metho-
Fig. 3 A Response rate (responses/s) and drug intake (g/kg) for
monkeys trained to lever press on a fixed ratio of 30 responses for
each injection of ethanol (g/kg/inj) or saline (n=5). B, C Change in
plasma concentration of ACTH (B; baseline=6.0±0.41 pg/ml) and
cortisol (C; baseline=12.1±0.58 μg/dl) measured in venous blood
samples obtained before, during (in box) and after sessions during
which saline or ethanol was available for self-administration. D
Cumulative release of ACTH (pg min/ml) and cortisol (μg min/dl)
during self-administration of ethanol or saline. Key to symbols: a
Response rate significantly different from saline, 0.003 g/kg/inj and
0.1 g/kg/inj ethanol, b ACTH and cortisol levels significantly
different from 0.03 g/kg/inj (not shown) and 0.1 g/kg/inj ethanol, c
ACTH and cortisol levels for 0.003 g/kg/inj ethanol (not shown)
significantly different from 0.1 g/kg/inj ethanol, d Cortisol levels for
saline significantly different from 0.1 g/kg/inj ethanol, e Cortisol
levels significantly different from 0 (saline), (f) ACTH levels
significantly different from 0 (saline) and 0.003 g/kg/inj ethanol
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hexital on the subsequent HPA stimulation produced by
intravenous administration of CRH in rhesus monkeys.
Prior treatment with methohexital had no effect on the
ACTH or cortisol response following the CRH challenge
(Broadbear et al. 2004a). However, the differences in HPA
response when small and large doses of methohexital were
available for self-administration were unexpected. Rates of
responding maintained by the small doses did not differ
from responding maintained by saline; these doses
increased stress hormone levels but not enough for
statistical significance. On the other hand, larger doses
that did maintain self-administration behavior produced an
attenuation of ACTH and cortisol secretion. Intake of
methohexital equal to or greater than 7.5 mg/kg corre-
sponded to a reduction in pituitary–adrenal activity
relative to when smaller doses were available. Unlike
earlier studies, in which the HPA effects of single bolus
doses of barbiturates have been examined (Buckingham
1984; D’Haese and Camu 1993), this study examined a
range of doses, none of which was sufficient to produce
complete anesthetization. Thus, the contrast between the
effects of small and large doses on ACTH and cortisol
secretion has not been previously reported.
Although no dose of midazolam, a short-acting benzo-
diazepine, differed from saline in its effects on the HPA
axis in the present study, the large and small doses of
midazolam also varied from one another in their effects on
ACTH and cortisol secretion. As with methohexital, the
smallest dose of midazolam appeared to stimulate ACTH
and cortisol secretion relative to when the largest dose was
self-administered. Dose-related differences in the effect of
benzodiazepines in rats have been reported, although they
are opposite from what we report here. In rats, small doses
of diazepam decreased HPA activity (Pericic et al. 1984),
whereas larger doses stimulated HPA hormone secretion
(Kalman et al. 1997). In vitro studies using rat
hypothalami showed that alprazolam inhibited CRH
release via a serotonergic mechanism (Kalogeras et al.
1990), a result that is consistent with the in vivo findings
using small doses of benzodiazepines in rats. Alprazolam
in monkeys (Kalogeras et al. 1990), and temazepam
(Beary et al. 1983) and alprazolam (Charney et al. 1986) in
humans, tended to decrease basal levels of cortisol and
ACTH as was found in the present study. The experi-
mental procedure and findings of both the present study
and that of Kalogeras et al. (1990) are similar. In both
studies, monkeys with indwelling catheters were tested in
their home cages. Kalogeras et al. (1990) measured a
clearly dose-dependent reduction in ACTH and cortisol
following IV alprazolam administration, although alpra-
zolam was administered as a single bolus dose, as opposed
to the pattern of self-injected doses taken by the monkeys
in the present study.
In addition to reducing basal HPA activity, treatment
with benzodiazepines has been shown to attenuate the
HPA response to subsequent challenges such as insulin-
induced hypoglycemia in monkeys (VanVugt et al. 1997),
and exogenous CRH (Korbonits et al. 1995) and a “mental
stress task” in humans (Rohrer et al. 1994). In the latter
study, Rohrer and colleagues found that although treat-
ment with alprazolam blunted the HPA response to a
stressful task, it did not attenuate the HPA response to
exogenous CRH. They concluded that alprazolam modu-
lated CRH secretion rather than pituitary responsiveness to
CRH. In contrast to the inhibitory modulation of the HPA
axis by benzodiazepine agonists, the opposite effect could
be measured following administration of inverse agonists
at the benzodiazepine receptor. Drugs such as β-carboline-
3-carboxylic acid ethyl ester (β-CCE) have been shown to
stimulate the HPA axis in rhesus monkeys (Insel et al.
1984; Takada et al. 1986; unpublished work from our
laboratory), further evidence that modulation of the HPA
axis by benzodiazepines is a receptor-based phenomenon.
Ethanol had a clearly inhibitory effect on ACTH and
cortisol secretion in the present study, as larger doses
decreased both hormones relative to smaller doses as well
as to saline. Although AUC cortisol levels appeared higher
when saline was available to monkeys in the ethanol self-
administration group, statistical analysis of the data at each
sampling time found no significant difference in the
ACTH or cortisol responses to saline in the monkeys in
any of the three drug groups. Despite this, it is possible
that when the drug being tested (ethanol in this case) has a
tendency to inhibit basal stress hormone release, a
conditioned, compensatory rise in hormone secretion
may be revealed when saline is substituted (i.e. when
drug is absent) during testing. A similar effect was also
observed during the self-administration of fentanyl,
another drug that inhibited stress hormone secretion,
when fentanyl was tested under the same experimental
conditions (Broadbear et al. 2004b).
We recently published a study evaluating the behavioral
and hormonal effects of intravenously self-administered
ethanol (0.03 g/kg/inj) following pretreatment with the
opioid antagonist, naltrexone, in rhesus monkeys (Wil-
liams et al. 2004). Although the ethanol intake was similar
to what is reported for this dose in the current study,
ACTH secretion did not differ significantly from when
saline was available. However, even though pretreatment
with naltrexone reduced ethanol intake from 1.9 g/kg to
0.3 g/kg, this intake of ethanol was sufficient to attenuate
the stimulatory effect of the antagonist on ACTH levels,
suggesting that ethanol had an inhibitory effect on the
naltrexone-activated HPA axis (Williams et al. 2004; see
also Cami et al. 1988), which is consistent with the
inhibitory effect of ethanol on basal hormone levels
reported in the present study.
The human literature generally describes ethanol as
having a stimulatory or neutral effect on HPA axis activity.
The maximum intake of intravenous ethanol in the present
study (2.4±0.2 g/kg when 0.1 g/kg/inj was available for
self-administration), was approximately double the
amount of ethanol ingested orally in the human studies.
The range of doses tested in humans was 0.7 g/kg (Lukas
and Mendelson 1988) to 1.0 g/kg or slightly higher (Stott
et al. 1987; Ida et al. 1992; McCaul et al. 2001). In the
majority of human studies, ethanol was consumed orally
within a designated time (between 10 min and 60 min). In
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the present study, 63% of the total intake of ethanol (0.1 g/
kg/inj) was self-administered during the first 25 min
component of the session (1.51±0.18 g/kg), and 85% of
the total intake was consumed by the end of the second
component (60 min after the start of the session), so the
pattern of intake of ethanol was similar to the human
subject studies. However, there remains the question of
how route of administration (oral versus intravenous) may
influence the effect of ethanol on the HPA axis. Davis and
Jeffcoate (1983) compared the effects of oral (1.0 g/kg)
and intravenous ethanol (0.81 g/kg) on cortisol in normal
males. However, these comparatively small doses of
ethanol had no effect on plasma cortisol in men following
administration by either the oral or intravenous route.
Historically, comparisons of the HPA effects of drugs of
abuse have been complicated by the myriad of procedural
differences between studies. The advantage of the current
study is that a variety of drugs were tested under the same
experimental conditions. The addition of data for metho-
hexital, midazolam and ethanol to our earlier study in
which cocaine, fentanyl and ketamine were examined
(Broadbear et al. 2004b), has revealed clear differences in
the ways in which different drugs of abuse, at doses that
are self-administered, affect basal HPA function in rhesus
monkeys. Despite the fact that all six drugs tested in these
two studies served as reinforcers, cocaine was the only
drug to reliably stimulate ACTH and cortisol release.
Fentanyl, ketamine and ethanol, despite their different
mechanisms of action, all decreased HPA axis activity at
the higher doses. Neither methohexital nor midazolam had
a systematic effect on basal HPA axis function.
Therefore it appears that stimulation of the HPA axis
may be a unique property of psychomotor stimulants such
as cocaine. Other classes of abused drugs do not appear to
share a common HPA effect when tested under the same
conditions, suggesting that there is a separation between
the stress hormone consequences of drug taking and the
capacity of a drug to maintain self-administration behavior
in rhesus monkeys.
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